Well actually you are saying that I am saying that they are saying that.
So do you think they were referring to the quality of the results of the trial or were they referring to the type of data that they will be releasing by the end of the month? I actually prefer "top line data" to "interim results".
LEAD PRODUCT: BTX 1503 (MODERATE TO SEVERE ACNE) - Phase 2 clinical trial, page-45
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.005(1.56%) |
Mkt cap ! $595.2M | |||
| Open | High | Low | Value | Volume |
| 33.5¢ | 34.8¢ | 32.0¢ | $2.794M | 8.302M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 621855 | 32.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 77983 | 3 |
View Market Depth
| Last trade - 14.40pm 14/11/2024 (20 minute delay) ? |
| BOT (ASX) Chart |